Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 68 checked references that resolve
resolves10.3390/molecules24101995NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
resolves10.1016/j.jinorgbio.2014.07.014Cinnamaldehyde and cuminaldehyde thiosemicarbazones and their copper(II) and nickel(II) complexes: A study to understand their biological activity
resolves10.1016/j.jinorgbio.2019.110725Computational studies, design and synthesis of Pd(II)-based complexes: Allosteric inhibitors of the Human Topoisomerase-IIα
resolves10.1039/D0DT00253DCytotoxic and apoptotic effects of ternary silver(
<scp>i</scp>
) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline
resolves10.1016/j.ica.2017.01.005Synthesis, characterization and in vitro biological activities of new water-soluble copper(II), zinc(II), and nickel(II) complexes with sulfonato-substituted Schiff base ligand
resolves10.1038/s41598-020-67439-yMechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study
resolves10.18596/jotcsa.472530Inhibition of DNase I Enzyme with Nickel(II) Triphenylphosphine Complexes Incorporating Tridentate Schiff Base Ligands in Vitro
resolves10.1038/onc.2016.114A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy
resolves10.1371/journal.pone.0100933Nickel(II) Complex of Polyhydroxybenzaldehyde N4-Thiosemicarbazone Exhibits Anti-Inflammatory Activity by Inhibiting NF-κB Transactivation
resolves10.1016/j.poly.2018.08.026Synthesis, characterization, crystal structure, electrochemical studies and biological evaluation of metal complexes with thiosemicarbazone of glyoxylic acid
resolves10.1016/j.inoche.2019.107708Palladium(II) complexes bearing thiosemicarbazone and phosphines as inhibitors of DNA-Topoisomerase II enzyme: Synthesis, characterizations and biological studies
resolves10.1016/j.ica.2018.11.022Orthopalladated acetophenone oxime compounds bearing thioamides as ligands: Synthesis, structure and cytotoxic evaluation
resolves10.1016/j.molstruc.2018.07.108Palladium orthometallated complexes containing acetophenoneoxime: Synthesis, crystal structures and hirshfeld surface analysis
resolves10.1007/s11243-017-0161-9Synthesis, characterization and antitumor activity of palladium(II) complexes of imidazolidine-2-thione
resolves10.1016/j.ica.2016.02.053DNA binding, topoisomerase inhibition and cytotoxicity of palladium(II) complexes with 1,10-phenanthroline and thioureas
resolves10.1007/s00044-015-1339-3C 2 ,N-dimethylbenzylamine cyclopalladated compounds: evaluation of cytotoxic, mutagenic and antitubercular activities
resolves10.1016/j.jfda.2017.03.006Anti-inflammatory effect of cinnamaldehyde and linalool from the leaf essential oil of Cinnamomum osmophloeum Kanehira in endotoxin-induced mice
resolves10.1107/S1399004714010372Combining biophysical methods for the analysis of protein complex stoichiometry and affinity in<i>SEDPHAT</i>
resolves10.1002/cbf.3135The use of erythrocyte fragility to assess xenobiotic cytotoxicity
resolves10.1002/jps.20627In vitro hemolysis: Guidance for the pharmaceutical scientist
resolves10.1016/j.peptides.2008.11.003Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (“spotted treefrog”)
resolves10.1021/bi00490a021Binding characteristics of Hoechst 33258 with calf thymus DNA, poly[d(A-T)] and d(CCGGAATTCCGG): multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities
resolves10.1039/C8RA09763AExperimental and theoretical evaluation on the antioxidant activity of a copper(
<scp>ii</scp>
) complex based on lidocaine and ibuprofen amide-phenanthroline agents
resolves10.1016/j.jphotochem.2020.112356Bis-azo-linkage Schiff bases—Part(II): Synthesis, characterization, photoluminescence and DPPH radical scavenging properties of their novel luminescent mononuclear Zn(II) complexes
resolves10.1016/j.poly.2015.12.029A ruthenium polypyridyl complex with the antihypertensive drug valsartan: Synthesis, theoretical calculations and interaction studies with human serum albumin
resolves10.1155/2013/524701Synthesis and Characterization of New Palladium(II) Thiosemicarbazone Complexes and Their Cytotoxic Activity against Various Human Tumor Cell Lines
resolves10.1021/jm0512241Novel Antitrypanosomal Agents Based on Palladium Nitrofurylthiosemicarbazone Complexes: DNA and Redox Metabolism as Potential Therapeutic Targets
resolves10.1016/0022-1759(83)90303-4Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
resolves10.3390/ijms17050781Novel Zinc(II) Complexes [Zn(atc-Et)2] and [Zn(atc-Ph)2]: In Vitro and in Vivo Antiproliferative Studies
resolves10.1039/C7QI00299HA new class of platinum(
<scp>ii</scp>
) complexes with the phosphine ligand pta which show potent anticancer activity
resolves10.1016/j.bmc.2005.09.007The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC)·poly(rG): Spectroscopic and viscometric study
resolves10.1021/bi020135cIntercalation of an Acridine−Peptide Drug in an AA/TT Base Step in the Crystal Structure of [d(CGCGAATTCGCG)]<sub>2</sub> with Six Duplexes and Seven Mg<sup>2+</sup> Ions in the Asymmetric Unit
resolves10.1038/377649a0Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin
resolves10.1016/j.ica.2020.119824DNA binding, cleavage, apoptosis and cytotoxicity studies of three heteroleptic nickel complexes bearing β-diketones
resolves10.1039/C8CS00157JMolecular methods for assessment of non-covalent metallodrug–DNA interactions
resolves10.1021/ja00190a046Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA
resolves10.1016/j.jpba.2018.09.022New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy
resolves10.1016/j.jlumin.2018.05.066Fluorescence spectroscopy, molecular docking and molecular dynamic simulation studies of HSA-Aflatoxin B1 and G1 interactions
resolves10.1016/j.jlumin.2017.03.041Effects of plant extract aurantio-obtusin on pepsin structure: Spectroscopic characterization and docking simulation
resolves10.2174/1381612821666150304163447Understanding the Physical and Chemical Nature of the Warfarin Drug Binding Site in Human Serum Albumin: Experimental and Theoretical Studies
resolves10.1021/jp311238nBinding of Hydroxyquinoline Probes to Human Serum Albumin: Combining Molecular Modeling and Förster’s Resonance Energy Transfer Spectroscopy to Understand Flexible Ligand Binding
resolves10.3390/molecules25051192Antioxidant Properties of Camphene-Based Thiosemicarbazones: Experimental and Theoretical Evaluation
The 12 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.msec.2020.111815_bb0010
no DOI — not checked10.1016/j.msec.2020.111815_bb0030
no DOI — not checked10.1016/j.msec.2020.111815_bb0055
no DOI — not checked10.1016/j.msec.2020.111815_bb0130
no DOI — not checked10.1016/j.msec.2020.111815_bb0135
no DOI — not checked10.1016/j.msec.2020.111815_bb0140
no DOI — not checked10.1016/j.msec.2020.111815_bb0160
no DOI — not checked10.1016/j.msec.2020.111815_bb0170
no DOI — not checked10.1016/j.msec.2020.111815_bb0220
no DOI — not checked10.1016/j.msec.2020.111815_bb0245
no DOI — not checked10.1016/j.msec.2020.111815_bb0295
no DOI — not checkedInorganic electronic spectroscopy
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.